Literature DB >> 29263739

Hypophosphatasia: clinical manifestation and burden of disease in adult patients.

Francesco Conti1, Lorenzo Ciullini1, Giuseppe Pugliese1.   

Abstract

Hypophosphatasia (HPP) is a rare inherited disease with a heterogeneous clinical expression. The adult form of HPP is often difficult to be recognized with a delayed diagnosis and inappropriate treatments. Though severity of HPP decreases with age at onset, important complications could occur at any age and the burden of HPP among adult patients is found to be significant. Adult patients with HPP suffer of chronic pain, recurrent fractures and other orthopedics problems, with severe disability that have a serious negative impact on all aspects of their life. The aim of this paper is to summarize the main aspects of HPP in adult patients reviewing the literature and focusing on its burden for patients suffering from this condition.

Entities:  

Keywords:  adult form; alkaline phosphatase; bone; diagnosis; fractures; hypophosphatasia

Year:  2017        PMID: 29263739      PMCID: PMC5726215          DOI: 10.11138/ccmbm/2017.14.1.230

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  23 in total

Review 1.  Physiological role of alkaline phosphatase explored in hypophosphatasia.

Authors:  Michael P Whyte
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

2.  Hypophosphatasia update: recent advances in diagnosis and treatment.

Authors:  D E C Cole
Journal:  Clin Genet       Date:  2007-01-08       Impact factor: 4.438

3.  Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers.

Authors:  Atsushi Watanabe; Tatsuki Karasugi; Hideaki Sawai; Banyar Than Naing; Shiro Ikegawa; Hideo Orimo; Takashi Shimada
Journal:  J Hum Genet       Date:  2010-12-23       Impact factor: 3.172

4.  Clinical spectrum of hypophosphatasia diagnosed in adults.

Authors:  Kathryn E Berkseth; Peter J Tebben; Matthew T Drake; Theresa E Hefferan; Donna E Jewison; Robert A Wermers
Journal:  Bone       Date:  2013-01-22       Impact factor: 4.398

Review 5.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

6.  Treatment of adult hypophosphatasia with teriparatide.

Authors:  Pauline M Camacho; Stephanie Painter; Ruth Kadanoff
Journal:  Endocr Pract       Date:  2008-03       Impact factor: 3.443

Review 7.  Hypophosphatasia.

Authors:  Etienne Mornet
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

8.  Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia.

Authors:  M D McKee; Y Nakano; D L Masica; J J Gray; I Lemire; R Heft; M P Whyte; P Crine; J L Millán
Journal:  J Dent Res       Date:  2011-01-06       Impact factor: 6.116

Review 9.  Pathophysiology of hypophosphatasia and the potential role of asfotase alfa.

Authors:  Hideo Orimo
Journal:  Ther Clin Risk Manag       Date:  2016-05-17       Impact factor: 2.423

Review 10.  Alkaline Phosphatase and Hypophosphatasia.

Authors:  José Luis Millán; Michael P Whyte
Journal:  Calcif Tissue Int       Date:  2015-11-21       Impact factor: 4.333

View more
  9 in total

1.  A novel de novo heterozygous ALPL nonsense mutation associated with adult hypophosphatasia.

Authors:  L Martins; E L Dos Santos; A B de Almeida; R A Machado; A M Lyrio; B L Foster; K R Kantovitz; R D Coletta; F H Nociti
Journal:  Osteoporos Int       Date:  2020-06-23       Impact factor: 4.507

Review 2.  [Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases?]

Authors:  J Knitza; A Kleyer; G Schett; B Manger
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

Review 3.  Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.

Authors:  Sreyanko Sadhukhan; Poonam Mehta; Singh Rajender; Sushil Kumar Gupta; Naibedya Chattopadhyay
Journal:  Osteoporos Int       Date:  2022-07-01       Impact factor: 4.507

4.  Dental manifestations in adult hypophosphatasia and their correlation with biomarkers.

Authors:  Priya Sinha; Rachel Gabor; Rachael Haupt-Harrington; Leila Deering; Robert D Steiner
Journal:  JIMD Rep       Date:  2022-06-28

5.  Impact of discontinuing 5 years of enzyme replacement treatment in a cohort of 6 adults with hypophosphatasia: A case series.

Authors:  Cheryl Rockman-Greenberg; Robert Josse; Mira Francis; Aziz Mhanni
Journal:  Bone Rep       Date:  2022-08-30

6.  ADULT-ONSET HYPOPHOSPHATASIA: BEFORE AND AFTER TREATMENT WITH ASFOTASE ALFA.

Authors:  Angela L Magdaleno; Sonum Singh; Sandhya Venkataraman; Gretchen A Perilli; Ya-Yu Lee
Journal:  AACE Clin Case Rep       Date:  2019-08-15

Review 7.  Bone health in patients with inborn errors of metabolism.

Authors:  M Langeveld; C E M Hollak
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 8.  Tissue Non-Specific Alkaline Phosphatase and Vascular Calcification: A Potential Therapeutic Target.

Authors:  Daniel Azpiazu; Sergio Gonzalo; Ricardo Villa-Bellosta
Journal:  Curr Cardiol Rev       Date:  2019

9.  Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia.

Authors:  Wei-Jian Pan; Rajendra Pradhan; Ryan Pelto; Lothar Seefried
Journal:  J Clin Pharmacol       Date:  2021-06-19       Impact factor: 3.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.